Quarterly report pursuant to Section 13 or 15(d)

Debt and Interest (Tables)

v3.7.0.1
Debt and Interest (Tables)
3 Months Ended
Mar. 31, 2017
Debt Disclosure [Abstract]  
Schedule Of Interest Expenses
Total debt consists of the following as of March 31, 2017 and December 31, 2016:
 
 
 
March 31,
 
December 31,
 
 
 
 
 
($ in thousands)
 
2017
 
2016
 
Interest rate
 
Maturity
 
IDB Note
 
$
14,929
 
$
14,929
 
2.25%
 
Feb - 2018
 
NSC Note
 
 
3,608
 
 
3,608
 
8.00%
 
Sep - 2018
 
2017 Subordinated Note Financing
 
 
3,254
 
 
-
 
8.00%
 
March - 2020
 
Opus Credit Facility
 
 
9,000
 
 
7,000
 
12.00%
 
Sep - 2018
 
Helocyte Convertible Note, at fair value
 
 
1,054
 
 
1,031
 
5.00% - 8.00%
 
December 2017
 
Helocyte Convertible Note, at fair value
 
 
2,093
 
 
2,051
 
5.00% - 8.00%
 
March - 2018
 
Helocyte Convertible Note, at fair value
 
 
1,011
 
 
991
 
5.00% - 8.00%
 
April - 2018
 
Helocyte Convertible Note, at fair value
 
 
422
 
 
414
 
5.00% - 8.00%
 
May - 2018
 
Avenue Convertible Note, at fair value
 
 
204
 
 
200
 
5.00% - 8.00%
 
June - 2018
 
Total notes payable
 
 
35,575
 
 
30,224
 
 
 
 
 
Less: Discount on notes payable
 
 
2,549
 
 
2,009
 
 
 
 
 
Total notes payable, net
 
$
33,026
 
$
28,215
 
 
 
 
 
Schedule Of Interest Expenses For Debt Arrangements
The following table shows the details of interest expense for all debt arrangements during the periods presented. Interest expense includes contractual interest and amortization of the debt discount and amortization of fees represents fees associated with loan transaction costs, amortized over the life of the loan:
 
 
 
For the Three Months Ended March 31,
 
($ in thousands)
 
2017
 
2016
 
IDB Note
 
 
 
 
 
 
 
Interest
 
$
82
 
$
80
 
Amortization of fees
 
 
-
 
 
1
 
Total IDB Note
 
 
82
 
 
81
 
 
 
 
 
 
 
 
 
NSC Debt
 
 
 
 
 
 
 
Interest
 
 
71
 
 
167
 
Amortization of fees
 
 
38
 
 
368
 
Total NSC Debt
 
 
109
 
 
535
 
 
 
 
 
 
 
 
 
Opus Credit Facility
 
 
 
 
 
 
 
Interest
 
 
232
 
 
-
 
Amortization of fees
 
 
208
 
 
-
 
Total Opus Note
 
 
440
 
 
-
 
 
 
 
 
 
 
 
 
LOC Fees
 
 
 
 
 
 
 
Interest
 
 
8
 
 
4
 
Total LOC
 
 
8
 
 
4
 
 
 
 
 
 
 
 
 
Helocyte Convertible Note
 
 
 
 
 
 
 
Interest
 
 
54
 
 
-
 
Financing fee
 
 
1
 
 
-
 
Total Helocyte Convertible Note
 
 
55
 
 
-
 
 
 
 
 
 
 
 
 
Avenue Convertible Note
 
 
 
 
 
 
 
Financing fee
 
 
3
 
 
-
 
Total Helocyte Convertible Note
 
 
3
 
 
-
 
 
 
 
 
 
 
 
 
D&O Insurance
 
 
 
 
 
 
 
Interest
 
 
1
 
 
-
 
Total D&O Insurance
 
 
1
 
 
-
 
Total Interest Expense and Financing Fee
 
$
698
 
$
620